Axsome Therapeutics

Axsome's sleep disorder drug succeeds in late-stage trial, shares rise
Reuters
Mon, 03/25/24 - 11:22 am
Axsome Therapeutics
narcolepsy
clinical trials
AXS-12
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Where Will Axsome Therapeutics Be in 3 Years?
Motley Fool
Tue, 06/20/23 - 10:02 am
Axsome Therapeutics
Sunosi
Auvelity
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner 
Endpoints
Mon, 02/27/23 - 10:19 am
Axsome Therapeutics
FDA
clinical trials
Alzheimer's disease agitation
Alzheimer's disease
AXS-05
Axsome Headed to FDA after Phase III Alzheimer's Agitation Win
BioSpace
Mon, 11/28/22 - 10:23 am
Axsome Therapeutics
clinical trials
Alzheimer's disease
Alzheimer's agitation
AXS-05
3 Biopharmas on Buyout Watch
Motley Fool
Mon, 08/22/22 - 10:39 am
M&A
Axsome Therapeutics
Alnylam Pharmaceuticals
Karuna Therapeutics
Axsome's depression drug enters competitive market after U.S. approval
Reuters
Fri, 08/19/22 - 10:37 am
Axsome Therapeutics
clinical depression
FDA
Auvelity
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
Fierce Biotech
Mon, 05/2/22 - 06:19 pm
Axsome Therapeutics
migraines
FDA
AXS-07
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
BioSpace
Mon, 05/2/22 - 11:44 am
FDA
complete response letter
Junshi Biosciences
Coherus Biosciences
Axsome Therapeutics
migraines
AXS-07
Axsome expects migraine drug to be rejected as manufacturing issues arise
Endpoints
Mon, 04/25/22 - 10:42 am
Axsome Therapeutics
migraines
FDA
AXS-07
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
Motley Fool
Sat, 04/23/22 - 03:54 pm
Novavax
vaccines
COVID-19
Axsome Therapeutics
FDA
Novocure
lung cancer
Axsome and Aytu's Positive Day with the FDA
BioSpace
Tue, 04/19/22 - 11:54 pm
FDA
Axsome Therapeutics
Aytu BioSciences
depression
Vascular Ehlers-Danos Syndrome
Axsome moves 'closer to judgement day' for stalled depression therapy
Fierce Biotech
Tue, 04/19/22 - 11:05 am
Axsome Therapeutics
FDA
depression
AXS-05
Once heralded as its next big cash cow, Jazz takes a marked down price for not-so-hot sleep disorder drug
Endpoints
Mon, 03/28/22 - 07:49 pm
Jazz Pharma
Sunosi
Axsome Therapeutics
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
Motley Fool
Sun, 10/17/21 - 10:57 pm
ChemoCentryx
Ocular Therapeutics
Axsome Therapeutics
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road
Fierce Biotech
Mon, 08/23/21 - 11:08 am
Axsome Therapeutics
depression
FDA
Could Biogen Acquire Axsome Therapeutics?
Motley Fool
Fri, 08/20/21 - 10:56 am
Biogen
Axsome Therapeutics
M&A
Why Axsome Therapeutics Is Plunging Again Tuesday
Motley Fool
Tue, 08/10/21 - 11:14 pm
Axsome Therapeutics
FDA
AXS-05
Go or no go? August FDA decisions for Axsome, Sanofi and Merck
EP Vantage
Fri, 07/30/21 - 11:04 am
FDA
Axsome Therapeutics
Sanofi
Merck
Pompe disease
depression
kidney cancer
Keytruda

Pages